Whether to vaccinate is a fight people are still having. What to do if you’ve been exposed isn’t a fight — it’s just not well understood.

Do you know your immunity status? Should you get an MMR booster? Who do you even call? Is this an urgent care problem or an emergency room issue? And how do you get evaluated without turning a waiting room into a second outbreak?

Measles has resurfaced in the U.S. as a public health story, but underneath the headlines is a healthcare-navigation story that no one is talking about. Because we know how to prevent measles. We are much less organized about what happens after someone thinks they've been exposed. We don't know because for a generation, high vaccination rates kept exposures rare enough that most people, and most health systems, never had to build a playbook for it.

This isn't abstract. The CDC has confirmed more than 2,700 measles cases in the U.S. so far in 2026 — already surpassing all of 2025, which was itself the worst year for measles since 1991.

Five Questions Worth Answering Before You Need Them

Do I actually know whether I'm immune? Most adults have no idea where their childhood vaccination records are, if they ever existed. The CDC lays out a few paths to presumptive immunity: documented vaccination, lab-confirmed immunity, a prior case of measles, or birth before 1957.

But "I got the shot as a kid" isn't the end of the question — especially for Gen X. Anyone vaccinated between 1963 and 1967 may have gotten a since-discontinued "killed" version of the vaccine that didn't confer lasting immunity, and the CDC recommends revaccination for that group. A much larger group only ever got the single dose that was standard until 1989, before two doses became routine — still about 93% effective, but a real gap worth knowing about. Even fully, properly vaccinated people can show waning antibodies over time , though what that means clinically remains debated.

If any of that sounds like you, a blood test for measles IgG settles it — no need to guess and hope.

I've been exposed. Who do I call? Not the ER, and not a walk-in clinic, at least not first. Call ahead to our primary care provider so they can arrange testing or triage before you arrive, rather than walking in. Measles is airborne and extraordinarily contagious, and an unannounced arrival risks exposing an entire waiting room, including infants too young to be vaccinated and immunocompromised patients who can't be.

How quickly do I need to act? This is the part most people get wrong, because it's not intuitive. For someone without evidence of immunity, the CDC says MMR vaccination given within 72 hours of exposure can still prevent or modify the disease. Immune globulin has a longer window — up to six days — for certain higher-risk patients, including infants. Past those windows, the options narrow considerably. This is a case where "I'll deal with it this weekend" can be the difference between prevention and treatment.

Where should I actually receive care? A suspected case isn't a normal appointment. CDC guidance calls for immediate isolation, ideally in an airborne-infection isolation room, and instructs facilities to keep suspected patients out of waiting rooms and other common areas entirely. Some health systems go further, directing patients to a side entrance or even to stay in their car until they can be brought in directly. None of that happens if you're the person who walked in unannounced and mentioned your rash to the front desk.

Who's actually coordinating this? In a typical illness, coordination means you and your doctor. Measles adds the healthcare facility and local public health authorities to that list: CDC guidance for providers calls for immediate notification of health departments on any suspected case, which triggers testing, investigation and contact tracing well beyond your own visit. It's less "find a doctor" and more "activate a small system," and most patients have never been told that system exists.

What Makes This Different From a Vaccination Problem

It would be easy to file all of this under vaccine hesitancy. Bloomberg Philanthropies' Data for Health Initiative suggests that's an incomplete diagnosis. In the Caraga region of the Philippines, the initiative's Data to Policy team used better surveillance data to identify communities with low vaccination coverage and, more usefully, why coverage was low. The answer wasn't primarily hesitancy. It was that outlying health stations depended on irregular, point-to-point delivery from larger facilities, which meant limited sessions and real out-of-pocket burdens for families trying to reach them. The data helped make the case for upgrading select local facilities into "satellite vaccination hubs," stocked with refrigeration, backup power and supplies, so nearby communities could get more frequent, more reliable service.

The specifics don't map directly onto the U.S. — Caraga's outlying health stations and irregular vaccine deliveries are a starker logistics problem than most Americans face reaching a pharmacy or pediatrician's office. But the underlying lesson does travel: a lot of 'vaccine hesitancy' framing assumes the barrier is belief, when sometimes it's logistics — knowing where to go, how to get there, and whether the option will be available when you show up.

Measles being back doesn't just mean vaccination rates need attention. It means the entire experience of "what do I do now" needs a clearer answer than most people currently have.